Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Murphy

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patientsChristine H Chung, Erin H Seeley, Heinrich Roder, et al.
Journal of the American Medical Informatics Association : JAMIA|February 18, 2026
Closing the digital divide for hemodialysis patients: implementing technology training and support in a digital patient activation interventionTiffany C Veinot, Megan Wickens, Edward Hennessey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2021
Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO GuidelineValeria Mercadante, Siri Beier Jensen, Derek K Smith, et al.
Oral Oncology|June 19, 2018
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinomaRenata Ferrarotto, William N William, Jennifer E Tseng, et al.
Kidney International|May 27, 2020
Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosisZhongyang Zhang, Madhav C Menon, Weijia Zhang, et al.
Plos One|September 22, 2010
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinomaHiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth, et al.
Transplantation|February 23, 2018
Establishing a Core Outcome Measure for Graft Health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop ReportAllison Tong, Benedicte Sautenet, Emilio D Poggio, et al.
Critical Reviews in Oncology/Hematology|April 11, 2016
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statementMichela Buglione, Roberta Cavagnini, Federico Di Rosario, et al.
Cancers|December 3, 2020
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire DevelopmentPierluigi Bonomo, Alice Maruelli, Calogero Saieva, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 31, 2020
Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19Lili Chan, Suraj K Jaladanki, Sulaiman Somani, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patientsChristine H Chung, Erin H Seeley, Heinrich Roder, et al.
Journal of the American Medical Informatics Association : JAMIA|February 18, 2026
Closing the digital divide for hemodialysis patients: implementing technology training and support in a digital patient activation interventionTiffany C Veinot, Megan Wickens, Edward Hennessey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2021
Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO GuidelineValeria Mercadante, Siri Beier Jensen, Derek K Smith, et al.
Oral Oncology|June 19, 2018
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinomaRenata Ferrarotto, William N William, Jennifer E Tseng, et al.
Kidney International|May 27, 2020
Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosisZhongyang Zhang, Madhav C Menon, Weijia Zhang, et al.
Plos One|September 22, 2010
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinomaHiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth, et al.
Transplantation|February 23, 2018
Establishing a Core Outcome Measure for Graft Health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop ReportAllison Tong, Benedicte Sautenet, Emilio D Poggio, et al.
Critical Reviews in Oncology/Hematology|April 11, 2016
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statementMichela Buglione, Roberta Cavagnini, Federico Di Rosario, et al.
Cancers|December 3, 2020
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire DevelopmentPierluigi Bonomo, Alice Maruelli, Calogero Saieva, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 31, 2020
Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19Lili Chan, Suraj K Jaladanki, Sulaiman Somani, et al.
Pageof 17